Open AccessPhase Ib SEASTAR Study: Combining Rucaparib and Sacituzumab Govitecan in Patients With Cancer With or Without Mutations in Homologous Recombination Repair Genes
Author(s) -
Timothy A. Yap,
Erika Hamilton,
Todd M. Bauer,
Ecaterina E. Dumbrava,
Rinath Jeselsohn,
Aaron Enke,
Sabrina Hurley,
Kevin K. Lin,
Jenn Habeck,
Heidi Giordano,
Geoffrey I. Shapiro
Publication year - 2022
Publication title -
jco precision oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.405
H-Index - 22
ISSN - 2473-4284
DOI - 10.1200/po.21.00456
Subject(s) - parp inhibitor , homologous recombination , germline , biology , germline mutation , somatic cell , cancer , oncology , mutation , genetics , medicine , cancer research , gene , poly adp ribose polymerase , polymerase
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom